LianBio
LIANY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $801 | $1,327 | $1,005 | $526 |
| Gross Profit | -$801 | -$1,327 | -$1,005 | -$526 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,640 | $35,316 | $59,684 | $158,903 |
| G&A Expenses | $0 | $0 | $65,598 | $36,878 |
| SG&A Expenses | $27,417 | $62,900 | $64,515 | $36,878 |
| Sales & Mktg Exp. | $0 | $0 | -$1,083 | $0 |
| Other Operating Expenses | $0 | $1 | $0 | -$477 |
| Operating Expenses | $38,057 | $98,217 | $124,199 | $195,304 |
| Operating Income | -$38,858 | -$99,543 | -$125,204 | -$195,570 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $41,313 | $411,130 | $14,712 | -$212 |
| Pre-Tax Income | $2,454 | $311,587 | -$110,492 | -$196,042 |
| Tax Expense | -$22 | $450 | -$333 | $519 |
| Net Income | $2,476 | $311,137 | -$110,159 | -$196,561 |
| % Margin | – | – | – | – |
| EPS | 0.023 | 2.88 | -1.02 | -1.83 |
| % Growth | -99.2% | 382.4% | 44.3% | – |
| EPS Diluted | 0.023 | 2.87 | -1.02 | -1.83 |
| Weighted Avg Shares Out | 108,277 | 107,920 | 107,923 | 107,275 |
| Weighted Avg Shares Out Dil | 108,699 | 108,342 | 107,923 | 107,275 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,079 | $12,999 | $4,316 | $243 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $801 | $1,327 | $1,005 | $526 |
| EBITDA | $3,256 | $312,914 | -$109,487 | -$195,516 |
| % Margin | – | – | – | – |